COMMUNIQUÉS West-GlobeNewswire

Silexion Therapeutics Announces Groundbreaking Preclinical Results: SIL204 Shows Strong Efficacy in Pancreatic, Colorectal, and Lung Cancers
29/05/2025
Silexion’s Revolutionary RNAi approach demonstrates powerful anti-tumor activity across three major KRAS-driven cancer types; Inhibition rate of ~90% observed in GP2D human colorectal cancer cells; Company to conduct [...]
Positron Corporation Expands Market Presence with Sale of NeuSight PET-CT Scanner
29/05/2025
Niagara Falls, NY, May 29, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leader in molecular imaging systems and services, is pleased to announce the sale of its NeuSight PET [...]
Akari Therapeutics Releases “Meet the Team” Video Featuring Recently Appointed Mark F. Kubik, Head of Business Development – Oncology
29/05/2025
Well-established industry leader whose oncology expertise and transactions record has led to multiple approved therapeutic products and advanced clinical product candidates Access the video here BOSTON and LONDON, May [...]
HealthEquity Community Foundation Awards $35,000 in New Grants
29/05/2025
From food banks to crisis shelters, 14 nonprofits recognized for tackling urgent community needs DRAPER, Utah, May 29, 2025 (GLOBE NEWSWIRE) -- The HealthEquity Community Foundation™ today announced the recipients of [...]
Sienna Senior Living Inc. Announces Results From Annual and Special Meeting
29/05/2025
MARKHAM, Ontario, May 29, 2025 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) is pleased to announce that it has received shareholder approval in respect of all resolutions to [...]
Ensemble, On Marche à la Marche Percée DT1
29/05/2025
Tout au long du mois de juin, près de 50 communautés se réuniront dans tout le Canada pour amasser des fonds en faveur de la recherche sur le diabète de type 1 TORONTO, 29 mai 2025 (GLOBE NEWSWIRE) -- La Marche Percée [...]
Together we Walk at Breakthrough T1D Walk
29/05/2025
Throughout June close to 50 communities will be gathering across Canada to raise funds for type 1 diabetes research TORONTO, May 29, 2025 (GLOBE NEWSWIRE) -- Breakthrough T1D™ Walk (formerly JDRF Walk to Cure Diabetes) [...]
A Destructive Form of Cell Death Might Be The Key To Slowing The Human Aging Process
29/05/2025
Experts across scientific and clinical fields, writing in Nature Oncogene, explore the emerging role of necrosis in aging—pointing to its potential to reshape how we understand and treat age-related conditions CAMBRIDGE [...]
Keros Therapeutics Announces TROPOS Topline Data and Corporate Restructuring
29/05/2025
Discontinues Development of Cibotercept in PAH Announces Corporate Restructuring to Align Operations with Ongoing Strategic Priorities LEXINGTON, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros [...]
Dianthus Therapeutics to Webcast Presentation at the Jefferies Global Healthcare Conference
29/05/2025
NEW YORK and WALTHAM, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement [...]
Kymera Therapeutics to Participate in Upcoming June Investor Conferences
29/05/2025
WATERTOWN, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological [...]
Syndax Announces Participation in June Investor Conferences
29/05/2025
NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that Michael A. Metzger, Chief [...]
Axsome Therapeutics to Participate in Upcoming Investor Conferences
29/05/2025
NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that it will [...]
La Croix-Rouge canadienne vient en aide aux personnes touchées par les feux de forêt au Manitoba
29/05/2025
Service d’inscription offert et appel de fonds lancé OTTAWA, Ontario, 29 mai 2025 (GLOBE NEWSWIRE) -- La Croix-Rouge canadienne collabore présentement avec les autorités dirigeantes des communautés autochtones et tous [...]
Canadian Red Cross supporting people impacted by Manitoba wildfires
29/05/2025
Registration Services Opened and Appeal Launched OTTAWA, Ontario, May 29, 2025 (GLOBE NEWSWIRE) -- The Canadian Red Cross is currently working alongside Indigenous community leadership and all levels of government to [...]
Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
29/05/2025
DALLAS, May 28, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies [...]
Nxera Pharma Notes Neurocrine Biosciences Presents New Positive Data from Phase 2 Study of NBI-1117568 in Adults with Schizophrenia at American Society of Clinical Psychopharmacology 2025
29/05/2025
Tokyo, Japan and Cambridge, UK, 29 May 202 5 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) notes that Neurocrine Biosciences, Inc. announced that it had presented new positive data from the Phase 2 study [...]
argenx Announces Results of Annual General Meeting of Shareholders
28/05/2025
May 28, 2025 – 10:01 PM C ET Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, [...]
Corvus Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference
28/05/2025
SOUTH SAN FRANCISCO, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that members of its leadership team will conduct one [...]

Pages